Holen Sie sich die Stockscreener-App
4.83
2.51%
-0.15
Schlusskurs vom Vortag:
$4.98
Offen:
$4.96
24-Stunden-Volumen:
321.50K
Relative Volume:
0.25
Marktkapitalisierung:
$612.70M
Einnahmen:
$433.14M
Nettoeinkommen (Verlust:
$4.95M
KGV:
135.29
EPS:
0.0357
Netto-Cashflow:
$6.55M
1W Leistung:
+11.35%
1M Leistung:
+40.32%
6M Leistung:
+36.38%
1J Leistung:
+56.61%
1-Tages-Spanne:
$4.81
$4.96
1-Wochen-Bereich:
$4.30
$5.005
52-Wochen-Spanne:
$2.28
$6.71
Organogenesis Holdings Inc Stock (ORGO) Company Profile
Firmenname
Organogenesis Holdings Inc
Sektor
Telefon
781-575-0775
Adresse
85 DAN ROAD, CANTON, MA
Vergleichen Sie ORGO mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
ORGO
Organogenesis Holdings Inc
|
4.83 | 611.43M | 433.14M | 4.95M | 6.55M | 0.0357 |
|
ZTS
Zoetis Inc
|
153.22 | 67.31B | 9.29B | 2.52B | 2.28B | 5.57 |
|
TAK
Takeda Pharmaceutical Co Adr
|
14.65 | 45.95B | 30.08B | 710.16M | 4.45B | 0.2182 |
|
HLN
Haleon Plc Adr
|
9.825 | 43.35B | 14.35B | 1.85B | 0 | 0.4023 |
|
TEVA
Teva Pharmaceutical Industries Ltd Adr
|
16.44 | 18.68B | 16.54B | -1.64B | 749.00M | -1.45 |
|
UTHR
United Therapeutics Corp
|
305.02 | 13.44B | 2.99B | 1.21B | 1.13B | 25.06 |
Organogenesis Holdings Inc Stock (ORGO) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2024-06-28 | Eingeleitet | Lake Street | Buy |
| 2024-02-07 | Eingeleitet | Cantor Fitzgerald | Overweight |
| 2023-06-15 | Eingeleitet | Morgan Stanley | Equal-Weight |
| 2023-05-24 | Hochstufung | BTIG Research | Neutral → Buy |
| 2022-11-10 | Herabstufung | BTIG Research | Buy → Neutral |
| 2022-08-10 | Herabstufung | Oppenheimer | Outperform → Perform |
| 2020-01-10 | Eingeleitet | SVB Leerink | Outperform |
| 2019-08-26 | Fortgesetzt | Credit Suisse | Outperform |
| 2019-05-02 | Eingeleitet | Credit Suisse | Outperform |
| 2019-04-17 | Eingeleitet | Oppenheimer | Outperform |
| 2019-04-11 | Eingeleitet | SunTrust | Buy |
Alle ansehen
Organogenesis Holdings Inc Aktie (ORGO) Neueste Nachrichten
What drives Organogenesis Holdings Inc. stock priceExceptional growth trajectory - Autocar Professional
What analysts say about Organogenesis Holdings Inc. stock outlookDouble Profit With Half Risk - beatles.ru
Organogenesis Holdings Inc. Stock Analysis and ForecastExceptional growth trajectory - Autocar Professional
Discovering Opportunities: 3 Penny Stocks With Market Caps Over $200M - simplywall.st
What analysts say about Organogenesis Holdings Inc. stockExceptional portfolio growth - jammulinksnews.com
Is Organogenesis Holdings Inc. a good long term investmentHigh-profit stock alerts - jammulinksnews.com
Organogenesis Holdings Inc. Announces Q2 FY25 Financial Results Date and Conference Call Details - AInvest
Organogenesis Holdings Inc. to Report Second Quarter of Fiscal Year 2025 Financial Results on August 7, 2025 - The Manila Times
Lexeo Therapeutics (NASDAQ:LXEO) & Organogenesis (NASDAQ:ORGO) Head to Head Analysis - Defense World
Trade Desk Shares Surge 15% Amid S&P 500 Inclusion - AInvest
What makes Organogenesis Holdings Inc. stock price move sharplyProven Trading Plan - Newser
Why Organogenesis Holdings Inc. stock attracts strong analyst attentionFree Investment Risk Control - Newser
How Organogenesis Holdings Inc. stock performs during market volatilitySteady Income Ideas - Newser
Organogenesis applauds CMS’s proposed skin substitute payment changes By Investing.com - Investing.com Nigeria
Organogenesis applauds CMS’s proposed skin substitute payment changes - Investing.com Australia
Organogenesis Applauds CMS Proposal to Reform Skin Substitute Payment Policy; Urges Refinements to Ensure Patient Access to Appropriate Products and Continued Innovation - The Manila Times
Organogenesis stock rating reiterated by Cantor Fitzgerald amid reimbursement changes - Investing.com Canada
CMS Reform Backs Premium Wound Care Products, Organogenesis Leads Market Shift | ORGO Stock News - Stock Titan
Simulations Plus, FB Financial And Other Big Stocks Moving Lower In Tuesday's Pre-Market Session - Benzinga
Why Trade Desk Shares Are Trading Higher By 15%; Here Are 20 Stocks Moving Premarket - Benzinga
After-hours movers: FB Financial, MiMedx Group, Organogenesis, and more By Investing.com - Investing.com Canada
Organogenesis Holdings Inc.(NasdaqCM: ORGO) dropped from Russell 3000E Value Index - MarketScreener
Organogenesis Holdings Inc.(NasdaqCM: ORGO) dropped from Russell 3000 Value Index - MarketScreener
Is Organogenesis Holdings, Inc. overvalued or undervalued? - MarketsMojo
Organogenesis Holdings Leads The Charge With 2 Other Promising Penny Stocks - Yahoo Finance
Assenagon Asset Management S.A. Lowers Stock Holdings in Organogenesis (NASDAQ:ORGO) - Defense World
Organogenesis (NASDAQ:ORGO) Shares Acquired by Wealth Enhancement Advisory Services LLC - Defense World
Merit Financial Group LLC Makes New Investment in Organogenesis Holdings Inc. (NASDAQ:ORGO) - Defense World
Organogenesis Holdings leases 123,000 s/f at The Davis Cos.’ 100 Technology Way - NEREJ
Analysts Set Expectations for Organogenesis FY2026 Earnings - Defense World
Organogenesis Holdings: ReNu And New LCD Offer A Rebound Scenario - Seeking Alpha
Millennium Management LLC Raises Stock Position in Organogenesis Holdings Inc. (NASDAQ:ORGO) - Defense World
Ameriprise Financial Inc. Sells 61,072 Shares of Organogenesis Holdings Inc. (NASDAQ:ORGO) - Defense World
Insider Buying: Lori Freedman Acquires Shares in Organogenesis H - GuruFocus
Finanzdaten der Organogenesis Holdings Inc-Aktie (ORGO)
Umsatz
Nettogewinn
Free Cashflow
ENV
Organogenesis Holdings Inc-Aktie (ORGO) Insiderhandel
| Insiderhandel | Beziehung | Datum | Transaktion | Kosten | #Aktien | Wert ($) | #Aktien Gesamt |
|---|---|---|---|---|---|---|---|
| Freedman Lori | Chief Admin. and Legal Officer |
Jun 04 '25 |
Buy |
2.82 |
100,863 |
284,716 |
695,058 |
| Freedman Lori | Chief Admin. and Legal Officer |
Jun 06 '25 |
Buy |
2.99 |
9,022 |
26,949 |
846,459 |
3.78%
1.10%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):